[1]
“Regulatory Barriers and Harmonization Prospects for Generic Drug Approval in South Africa, Nigeria, Tanzania, and Zimbabwe”, AJP, vol. 19, no. 04, Jan. 2026, doi: 10.22377/ajp.v19i04.7092.